Peter Hammerman

Stealthy Third Rock start­up poach­es on­col­o­gy ex­ec from No­var­tis — just days af­ter his boss jumped ship

No­var­tis’ on­col­o­gy re­search unit has lost an­oth­er top ex­ec to biotech’s lure.

Pe­ter Ham­mer­man, the glob­al head of on­col­o­gy trans­la­tion­al re­search at NI­BR, re­vealed his …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.